Emmaus Life Financials
| EMMA Stock | USD 0.01 0.0001 0.71% |
With this module, you can analyze Emmaus financials for your investing period. You should be able to analyze the changes in Emmaus Life individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Emmaus |
Understanding current and past Emmaus Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Emmaus Life's financial statements are interrelated, with each one affecting the others. For example, an increase in Emmaus Life's assets may result in an increase in income on the income statement.
The data published in Emmaus Life's official financial statements typically reflect Emmaus Life's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Emmaus Life's quantitative information. For example, before you start analyzing numbers published by Emmaus accountants, it's essential to understand Emmaus Life's liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Emmaus Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Emmaus Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Emmaus Life's management manipulating its earnings.
Emmaus Life Stock Summary
Emmaus Life competes with Orgenesis, and Helix BioMedix. Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US29137T1016 |
| Business Address | 21250 Hawthorne Boulevard, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.emmausmedical.com |
| Phone | 310 214 0065 |
| Currency | USD - US Dollar |
Emmaus Life Key Financial Ratios
Emmaus Life's financial ratios allow both analysts and investors to convert raw data from Emmaus Life's financial statements into concise, actionable information that can be used to evaluate the performance of Emmaus Life over time and compare it to other companies across industries.Emmaus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Emmaus Life's current stock value. Our valuation model uses many indicators to compare Emmaus Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Emmaus Life competition to find correlations between indicators driving Emmaus Life's intrinsic value. More Info.Emmaus Life Sciences is one of the top stocks in return on asset category among its peers. It is rated # 3 in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Emmaus Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emmaus Life's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Emmaus Life February 2, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Emmaus Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Emmaus Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Emmaus Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Emmaus OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Emmaus Life's daily price indicators and compare them against related drivers.
| Downside Deviation | 10.26 | |||
| Information Ratio | 0.0878 | |||
| Maximum Drawdown | 64.24 | |||
| Value At Risk | (13.43) | |||
| Potential Upside | 20.37 |
Complementary Tools for Emmaus OTC Stock analysis
When running Emmaus Life's price analysis, check to measure Emmaus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emmaus Life is operating at the current time. Most of Emmaus Life's value examination focuses on studying past and present price action to predict the probability of Emmaus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emmaus Life's price. Additionally, you may evaluate how the addition of Emmaus Life to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |